Bristol Myers Squibb (BMY) Non Operating Income (2009 - 2026)
Bristol Myers Squibb (BMY) reported Non Operating Income of -$32.0 million for Q1 2026, up 90.56% year-over-year from -$16.8 million in Q1 2025, and down 162.75% on a QoQ basis from $51.0 million in Q4 2025.
Bristol Myers Squibb (BMY) has 18 years of Non Operating Income data on file, last reported at -$32.0 million in Q1 2026.
- Quarterly Non Operating Income rose 90.56% year-over-year to -$32.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$367.0 million (up 68.11% YoY) and the FY2025 annual result came in at -$674.0 million, up 24.52% from the prior year.
- Non Operating Income fell to -$32.0 million in Q1 2026 per BMY's latest filing, from $51.0 million in the prior quarter.
- Across five years, Non Operating Income topped out at $413.0 million in Q1 2023 and bottomed at -$649.0 million in Q1 2022.
- The 5-year median for Non Operating Income is -$32.0 million (2026), against an average of -$59.8 million.
- The widest annual swing landed in 2022, when Non Operating Income slumped 14300.0%; it then soared 163.64% in 2023.
- Tracing BMY's Non Operating Income over 5 years: stood at $217.0 million in 2022, then jumped by 70.97% to $371.0 million in 2023, then tumbled by 182.21% to -$305.0 million in 2024, then jumped by 116.72% to $51.0 million in 2025, then sank by 162.75% to -$32.0 million in 2026.
- Per Business Quant, the three latest BMY Non Operating Income figures stand at -$32.0 million (Q1 2026), $51.0 million (Q4 2025), and $108.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | -65.00 Mn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | -294.00 Mn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -2.31 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -138.00 Mn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 75.00 Mn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 235.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -861.00 Mn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -32.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.00 Mn |
| Dec 31, 2025 | 51.00 Mn |
| Sep 30, 2025 | 108.00 Mn |
| Jun 30, 2025 | -494.00 Mn |
| Mar 31, 2025 | -339.00 Mn |
| Dec 31, 2024 | -305.00 Mn |
| Sep 30, 2024 | -234.00 Mn |
| Jun 30, 2024 | -273.00 Mn |
| Mar 31, 2024 | -81.00 Mn |
| Dec 31, 2023 | 371.00 Mn |
| Sep 30, 2023 | 258.00 Mn |
| Jun 30, 2023 | 116.00 Mn |
| Mar 31, 2023 | 413.00 Mn |
| Dec 31, 2022 | 217.00 Mn |
| Sep 30, 2022 | 140.00 Mn |
| Jun 30, 2022 | -284.00 Mn |
| Mar 31, 2022 | -649.00 Mn |
| Dec 31, 2021 | -393.00 Mn |
| Sep 30, 2021 | 409.00 Mn |
| Jun 30, 2021 | 2.00 Mn |
| Mar 31, 2021 | 702.00 Mn |
| Dec 31, 2020 | 1.83 Bn |
| Sep 30, 2020 | 915.00 Mn |
| Jun 30, 2020 | 736.00 Mn |
| Mar 31, 2020 | -1.16 Bn |
| Dec 31, 2019 | -689.00 Mn |
| Sep 30, 2019 | -410.00 Mn |
| Jun 30, 2019 | -100.00 Mn |
| Mar 31, 2019 | 261.00 Mn |
| Dec 31, 2018 | -58.00 Mn |
| Sep 30, 2018 | 508.00 Mn |
| Jun 30, 2018 | 4.00 Mn |
| Mar 31, 2018 | 400.00 Mn |
| Dec 31, 2017 | 188.00 Mn |
| Sep 30, 2017 | 232.00 Mn |
| Jun 30, 2017 | 586.00 Mn |
| Mar 31, 2017 | 679.00 Mn |
| Dec 31, 2016 | 250.00 Mn |
| Sep 30, 2016 | 224.00 Mn |
| Jun 30, 2016 | 454.00 Mn |
| Mar 31, 2016 | 520.00 Mn |
| Dec 31, 2015 | -328.00 Mn |
| Sep 30, 2015 | 323.00 Mn |
| Jun 30, 2015 | -107.00 Mn |
| Mar 31, 2015 | 299.00 Mn |
| Dec 31, 2014 | -799.00 Mn |
| Sep 30, 2014 | 277.00 Mn |
| Jun 30, 2014 | 104.00 Mn |
| Mar 31, 2014 | 208.00 Mn |
| Dec 31, 2013 | -20.00 Mn |
| Sep 30, 2013 | -5.00 Mn |
| Jun 30, 2013 | -199.00 Mn |
| Mar 31, 2013 | 19.00 Mn |
| Dec 31, 2012 | -166.00 Mn |
| Sep 30, 2012 | 11.00 Mn |
| Jun 30, 2012 | 51.00 Mn |
| Mar 31, 2012 | 184.00 Mn |
| Dec 31, 2011 | 139.00 Mn |
| Sep 30, 2011 | 26.00 Mn |
| Jun 30, 2011 | 31.00 Mn |
| Mar 31, 2011 | 138.00 Mn |
| Dec 31, 2010 | 68.00 Mn |
| Sep 30, 2010 | 10.00 Mn |
| Jun 30, 2010 | 19.00 Mn |
| Mar 31, 2010 | -113.00 Mn |
| Dec 31, 2009 | 264.00 Mn |
| Sep 30, 2009 | 35.00 Mn |
| Jun 30, 2009 | 10.00 Mn |
| Mar 31, 2009 | 72.00 Mn |